Cardiac involvement in scleroderma

Area of Science:

• Cardiology
• Rheumatology
• Systemic Sclerosis Research

Background:

• Systemic sclerosis frequently involves the heart, manifesting in various forms like myocardial, pericardial, and conduction system diseases.
• Cardiac involvement in systemic sclerosis is a significant indicator of a poor prognosis.
• Abnormalities are more prevalent in diffuse scleroderma, with vascular involvement's role remaining uncertain.

Purpose of the Study:

• To summarize the clinical manifestations and prognostic implications of cardiac involvement in systemic sclerosis.
• To highlight the frequency of asymptomatic cardiac abnormalities.
• To discuss current therapeutic strategies and future research directions for cardiac scleroderma.

Main Methods:

• Review of clinical findings and prognostic factors in systemic sclerosis.
• Analysis of the prevalence of cardiac abnormalities based on disease subtype (diffuse scleroderma).
• Evaluation of current treatment approaches and identification of areas for further investigation.

Main Results:

• Cardiac involvement in systemic sclerosis presents as myocardial, pericardial, conduction system disease, or arrhythmias.
• Clinical cardiac involvement is a poor prognostic factor.
• Asymptomatic cardiac abnormalities are frequent, particularly in diffuse scleroderma.

Conclusions:

• Cardiac manifestations are a critical aspect of systemic sclerosis, impacting prognosis significantly.
• Current treatments for cardiac scleroderma are primarily symptomatic and empirical.
• Further research is essential to explore the potential of vasodilation and immunosuppression in managing cardiac scleroderma.